Hadassah head to be jabbed with blue-and-white vaccine Monday
Prof. Zeev Rotstein will be inoculated on Monday with the Israel Institute for Biological Institute vaccine candidate, Brilife, as part of its Phase II clinical trial.
Photo of Prof. Zeev Rotstein, head of Hadassah-University Medical Center, being screened for eligibility to be vaccinated on Monday as part of the Phase II trial of the Israeli vaccine candidate Brilife. December 20, 2020(photo credit: HADASSAH)ByMAAYAN JAFFE-HOFFMANUpdated:
